MedTrace Logo

Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

NCT01475877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-03

No results posted yet for this study

Summary

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Conditions

  • Myopia

Interventions

DRUG

Bromfenac

Bromfenac 0.09% 1 drop in study eyes q day

Sponsors & Collaborators

  • Virdi Eye Clinic

    lead OTHER

Principal Investigators

  • Navaneet S Borisuth, MD,PhD · Virdi Eye Clinic

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01475877 on ClinicalTrials.gov